Narwhal Capital Management Has $2.81 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Narwhal Capital Management cut its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 29.8% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 7,335 shares of the company’s stock after selling 3,115 shares during the quarter. Narwhal Capital Management’s holdings in HCA Healthcare were worth $2,810,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HCA. Brighton Jones LLC bought a new position in HCA Healthcare during the fourth quarter worth about $1,021,000. UMB Bank n.a. lifted its stake in HCA Healthcare by 19.1% during the first quarter. UMB Bank n.a. now owns 1,588 shares of the company’s stock worth $549,000 after purchasing an additional 255 shares during the period. OLD National Bancorp IN lifted its stake in HCA Healthcare by 5.2% during the first quarter. OLD National Bancorp IN now owns 1,049 shares of the company’s stock worth $362,000 after purchasing an additional 52 shares during the period. Farther Finance Advisors LLC lifted its stake in HCA Healthcare by 26.9% during the first quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company’s stock worth $395,000 after purchasing an additional 242 shares during the period. Finally, Pallas Capital Advisors LLC bought a new position in shares of HCA Healthcare in the first quarter valued at approximately $357,000. Institutional investors own 62.73% of the company’s stock.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares of the company’s stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is owned by company insiders.

Analysts Set New Price Targets

HCA has been the subject of a number of research analyst reports. Bank of America lifted their target price on shares of HCA Healthcare from $375.00 to $410.00 and gave the company a “neutral” rating in a research note on Wednesday, September 10th. Wells Fargo & Company lifted their target price on shares of HCA Healthcare from $375.00 to $412.00 and gave the company an “equal weight” rating in a research note on Tuesday. Weiss Ratings reiterated a “buy (b-)” rating on shares of HCA Healthcare in a research note on Wednesday. Royal Bank Of Canada dropped their price objective on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating for the company in a research report on Monday, July 28th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $422.31.

HCA Healthcare Stock Performance

HCA opened at $426.09 on Thursday. The company has a fifty day moving average price of $402.68 and a two-hundred day moving average price of $374.46. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $439.01. The firm has a market capitalization of $99.70 billion, a PE ratio of 17.91, a P/E/G ratio of 1.38 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same quarter in the previous year, the business earned $5.50 EPS. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were issued a $0.72 dividend. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s payout ratio is 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.